The name "Zhe Su" maps to multiple distinct researchers. OpenAlex lists at least three distinct author profiles (ORCID 0000-0001-8683-5700 with 69 works, h-index 22, ~10,653 citations; ORCID 0000-0002-0889-4198 with 96 works, h-index 34; ORCID 0000-0003-2883-6996 with 44 works, h-index 9), while the supplied citation record shows only 6 papers, h-index 4, and 116 citations β on hydrogel sensors, TADF OLEDs, shale permeability, and H2S probes. This fragmentation means any single-author assessment is inherently uncertain; name disambiguation is the dominant blindspot here.
The strongest work is the UT-AIM250 ancestry panel (quality 8, reproducibility 9, with public code and validation across 1000 Genomes AMR, TCGA-LIHC, and an HCC cohort of 26 patients), and the anti-windup wide-area damping controller paper (quality 8, damping ratio improved from 0.0172 to 0.3172, validated by Opal-RT RTDS hardware-in-the-loop) .
The orthostatic hypotension study (n=282, 69.86% incidence) is solidly powered but retrospective and single-center, with OH detection dependent on clinician assessment and unmeasured confounders such as hydration and analgesia . The BDNF-ketamine trial is a notable negative result (BDNF changes showed no correlation with antisuicidal response, all |r| < 0.17, all p > 0.28) β publishing a null finding against prevailing biomarker enthusiasm is epistemically commendable β but it is single-arm, open-label, and uses peripheral BDNF as an imperfect proxy for central levels . The Ma'erkang seismology paper is competent sequence analysis (hβ1.09, pβ1.02, b=0.95) but relies on evolving station coverage and small numbers of MLβ₯4 events .
The citation record shows an h-index of 4 with 116 total citations across 6 papers β a modest early-career profile. The OpenAlex ambiguity (h-indices of 22, 34, and 9 attached to different "Zhe Su" identities) means metrics cannot be reliably attributed without manual ORCID verification. The portfolio spans orthopedics, psychiatry, seismology, power engineering, and genomics β unusual breadth that suggests either a shared-name conflation or a highly mobile collaborator rather than deep specialization in one field. Counterpoint: given the disambiguation problem, any low score reflects metadata uncertainty as much as author capability.
Bottom line: Evidence quality ranges from 4 (a critique-only commentary with no new data) to 8 (two well-validated, reproducible studies). Best falsification test: confirm ORCID 0000-0001-8683-5700 to separate the true author's work and re-score.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.